Ubiquitin specific peptidase 1 promotes hepatic fibrosis through positive regulation of CXCL1 by deubiquitinating SNAIL
Open accessAbstract
Background Hepatic fibrosis is attributed to an imbalance of extracellular matrix production and lysis. Human hepatic stellate cells (HSCs) have been uncovered to converge through complex interactions with hepatocytes and immune cells, causing scarring in liver damage. Aims We aimed to investigate the expression status of ubiquitin specific peptidase 1 (USP1) and its potential mechanisms on HSCs and hepatic fibrosis. Methods Hepatic fibrosis animal and cell models were generated using mice with carbon tetrachloride (CCl4) treatment and HSCs LX-2 with TGF-β1 treatment. Relationships among USP1, SNAIL, and CXCL1 were identified via dual-luciferase reporter gene assay, co-immunoprecipitation, and chromatin immunoprecipitation. With gain- and loss-of-experiments, CCK-8 and flow cytometry assays were employed for cell proliferation and apoptosis. Results USP1 upregulated SNAIL expression through deubiquitination to increase CXCL1 expression. USP1 downregulation decreased expressions of fibrosis-related genes, suppressed proliferation, and promoted apoptosis in TGF-β1-induced LX-2 cells, which were reversed by SNAIL overexpression. The pro-fibrosis role caused by SNAIL upregulation was abolished by CXCL1 reduction. Promotive function of USP1/SNAIL/CXCL1 axis in hepatic fibrosis was further confirmed in vivo. Conclusion These data supported siRNA-mediated silencing of USP1 improved hepatic fibrosis through inhibition of SNAIL and CXCL1, which yields a new therapeutic target for hepatic fibrosis treatment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
siUSP1 can inhibit the CXCL1 pathway and further reduce hepatic stellate cell proliferation.
“siUSP1 can inhibit the Chemokine (C‐X‐C motif) Ligand 1 Protein (CXCL1) pathway[ 25 ] and further reduce HSCs proliferation.”
From An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis (2024) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Tao, R., Fan, X., Yu, H., Ai, G., Zhang, H., Kong, H., Song, Q., Huang, Y., Huang, J., & Ning, Q. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26475 · Cited by 71 · see citing works
RetractedCollagen Structure and Stability
Shoulders, M. D., & Raines, R. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.032207.120833 · Cited by 3,923 · see citing works
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · see citing works
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · see citing works
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo‐Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,389 · see citing works
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 759 · see citing works
Taki, M., Abiko, K., Baba, T., Hamanishi, J., Yamaguchi, K. D., Murakami, R., Yamanoi, K., Horikawa, N., Hosoe, Y., Nakamura, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03966-7 · Cited by 296 · see citing works
Mu, M., Zuo, S., Wu, R.-M., Deng, K., Lü, S., Zhu, J., Zou, G.-L., Yang, J., Cheng, M., & Zhao, X. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s186726 · Cited by 186 · see citing works
Böttcher, K., & Pinzani, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.016 · Cited by 183 · see citing works
Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
Cai, X., Wang, J., Wang, J., Zhou, Q., Yang, B., He, Q., & Weng, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104720 · Cited by 167 · see citing works
Raghuwanshi, S. K., Su, Y., Singh, V., Haynes, K., Richmond, A. J., & Richardson, R. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201114 · Cited by 150 · see citing works
USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability
Sonego, M., Pellarin, I., Costa, A., Vinciguerra, G. L. R., Coan, M., Kraut, A., D’Andrea, S., Dall’Acqua, A., Castillo‐Tong, D. C., Califano, D., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav3235 · Cited by 127 · see citing works
Modulation of hepatic stellate cells and reversibility of hepatic fibrosis
Huang, Y., Deng, X., & Liang, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.038 · Cited by 112 · see citing works
Shrestha, N., Chand, L., Han, M., Lee, S. O., Kim, C. Y., & Jeong, Y. J. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.04.024 · Cited by 97 · see citing works
Chemical and semisynthetic approaches to study and target deubiquitinases
Gopinath, P., Ohayon, S., Nawatha, M., & Brik, A. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00083e · Cited by 96 · see citing works
Epigenetic reprogramming in liver fibrosis and cancer
Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.011 · Cited by 96 · see citing works
Dufner, A., & Knobeloch, K. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190527 · Cited by 78 · see citing works
Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine
Gordillo‐Bastidas, D. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i47.9020 · Cited by 62 · see citing works
α-smooth muscle actin and ACTA2 gene expressions in vasculopathies
Yuan, S. (2015) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20150081 · Cited by 61 · see citing works
Li, S., Zhao, J., Shang, D., Kass, D. J., & Zhao, Y. (2018) · JCI Insight · doi:10.1172/jci.insight.120362 · Cited by 51 · see citing works
CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis
Shi, W., Ju, D., Li, H., Yuan, L., Cui, J., Luo, D., Chen, Z., & Bian, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041145 · Cited by 46 · see citing works
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Wang, Y., Song, J., Bian, H., Bo, J., Lv, S., Pan, W., & Lv, X. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03581-0 · Cited by 44 · see citing works
β‐Arrestin1 enhances liver fibrosis through autophagy‐mediated Snail signaling
Tan, S., Lu, Y., Xu, M., Huang, X., Liu, H., Jiang, J., & Wu, B. (2018) · The FASEB Journal · doi:10.1096/fj.201800828rr · Cited by 37 · see citing works
Small molecule inhibitor of HSP47 prevents pro-fibrotic mechanisms of fibroblasts in vitro
Miyamura, T., Sakamoto, N., Kakugawa, T., Taniguchi, H., Akiyama, Y., Okuno, D., Moriyama, S., Hara, A., Kido, T., Ishimoto, H., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.085 · Cited by 36 · see citing works
α‐SMA Overexpression Associated With Increased Liver Fibrosis in Infants With Biliary Atresia
Dong, R., Luo, Y., & Zheng, S. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182680be3 · Cited by 31 · see citing works
Li, Y., Xu, Y., Gao, C., Sun, Y., Zhou, K., Wang, P., Cheng, J., Guo, W., Cao, Y., Fan, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.554809 · Cited by 27 · see citing works
Cylindromatosis—A Protective Molecule against Liver Diseases
Hellerbrand, C., & Massoumi, R. (2016) · Medicinal Research Reviews · doi:10.1002/med.21381 · Cited by 26 · see citing works
Xiang, Z., JIANG, D.-P., Xia, G., WEI, Z.-W., CHEN, W., He, Y., & ZHANG, C.-H. (2015) · Oncology Letters · doi:10.3892/ol.2015.3614 · Cited by 26 · see citing works
New specific HSP47 functions in collagen subfamily chaperoning
Köhler, A., Mörgelin, M., Gebauer, J. M., Öcal, S., Imhof, T., Koch, M., Nagata, K., Paulsson, M., Aumailley, M., Baumann, U., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000570r · Cited by 25 · see citing works
Bi, W.-R., Jin, C., Xu, G., & Yang, C. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.720 · Cited by 21 · see citing works
Mutations in the ‘Fingers’ subdomain of the deubiquitinase USP 1 modulate its function and activity
Olazabal‐Herrero, A., García‐Santisteban, I., & Rodríguez, J. A. (2016) · FEBS Journal · doi:10.1111/febs.13648 · Cited by 9 · see citing works
Healing gone wrong: convergence of hemostatic pathways and liver fibrosis?
Davis, J. P. E., & Caldwell, S. H. (2020) · Clinical Science · doi:10.1042/cs20191102 · Cited by 9 · see citing works
Flagged first, then by citations
2 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Olazabal-Herrero A , Garcia-Santisteban I , Rodriguez JA . Mutations in the 'Fin- gers' subdomain of the deubiquitinase USP1 modulate its function and activity. FEBS J 2016;283:929-46 .
Cited by
Sorted by citations
Duan, B., Liu, Y., Li, X., Han, M., Yu, H., Hong, H., Zhang, L., Xing, L., & Jiang, H. (2024) · Advanced Science · doi:10.1002/advs.202306899 · Cited by 38 · see citing works
Kim, M. S., Baek, J.-H., Lee, J., Sivaraman, A., Lee, K., & Chun, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06317-7 · Cited by 34 · see citing works
Baek, J.-H., Kim, M. S., Jung, H. R., Hwang, M.-S., Lee, C.-H., Han, D. H., Lee, Y., Yi, E. C., Im, S., Hwang, I., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01036-7 · Cited by 23 · see citing works
Crosstalk of ubiquitin system and non-coding RNA in fibrosis
Zhang, H., Zhou, Y., Jiang, C., Jian, N., & Wang, J. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.93644 · Cited by 9 · see citing works
Chen, J., Zhang, R., Li, F., Lin, S., & Wang, J. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.07.010 · Cited by 9 · see citing works
Interleukin-9 promotes EMT-mediated PM2.5-induced pulmonary fibrosis by activating the STAT3 pathway
Li, Y., Zhong, Y., Li, C., Han, Z., Cui, Y., He, R., Liu, Y., Cui, Q., He, D., Hu, Z., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03864-6 · Cited by 8 · see citing works
CILP2 promotes hypertrophic scar through Snail acetylation by interaction with ACLY
Wang, J., Du, J., Wang, Y., Song, Y., Wu, J., Wang, T., Yu, Z., & Song, B. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167202 · Cited by 7 · see citing works
Deubiquitinases in metabolic diseases, fibrosis and cancer of the liver
Thakur, A., Kubaichuk, K. I., & Kietzmann, T. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120021 · Cited by 5 · see citing works
Zhao, Y., Zhang, F., Zhang, X., Li, Z., Li, Q., Ni, T., Wang, R., Liu, L., He, Y., & Zhao, Y. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.07.004 · Cited by 3 · see citing works
Self-citationDeubiquitinases in liver diseases: from mechanisms to targeted therapy.
Zhang, Z.-G., Duan, W., Wang, Y.-X., Hao, P., Chen, L., Hao, Z., He, M., Wu, Y., & Luo, H. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3100-1 · Cited by 3 · see citing works
Wang, D., Shi, Y., Lu, J., Bao, W. J., Wang, N., Shen, Q., Lin, Z., Qian, L., & Zhu, C. (2026) · Inflammation · doi:10.1007/s10753-025-02434-x · Cited by 2 · see citing works
Yin, R., Wu, C., Yu, S., Huang, K., Wen, Y., Nie, J., & Ying, R. (2025) · Cardiovascular Therapeutics · doi:10.1155/cdr/7892499
Zhu, M., Cui, L., Guo, Y., Tu, Y., Wang, Y., Zhou, W., Zhang, Y., Xie, L., & Jin, H. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.10.34
- Authors
- Du, Z., Wu, T., Liu, L., Luo, B., & Wei, C.
- Affiliations
- Jinan University (CN)
- First People’s Hospital of Jingmen (CN)
- Corresponding author
- Wei, Cuifeng
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 54
- Issue
- 1
- Pages
- 91-102
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W3159564328
- Cited by
- 13
- References
- 34
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 5
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Digestive and Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (201911, 81470868)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- liver fibrosis, USP1, snails, CXCL1, deubiquitination, hepatic stellate cells, TGF-β1, carbon tetrachloride, extracellular matrix, therapeutic target
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Gene Expression Regulation, Liver Cirrhosis, Up-Regulation, Gene Silencing, RNA, Small Interfering, Mice, Chemokine CXCL1, Hepatic Stellate Cells, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review